Efficacy Study of the Effect of Budesonide on Emphysema

• Status: Completed
• Trial end date: 2004-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the effect of up to 4 years treatment with budesonide on progression of emphysema in patients with Chronic Obstructive Lung Disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Budesonide

Criteria

Inclusion Criteria:

• Clinical Chronic Obstructive Pulmonary Disease diagnosis

• smoker

Exclusion Criteria:

• No exacerbation within the last 30 days

• no long term use of oral corticosteroids